KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Current Assets: 2018-2025

Historic Current Assets for Adaptive Biotechnologies (ADPT) over the last 7 years, with Sep 2025 value amounting to $281.4 million.

  • Adaptive Biotechnologies' Current Assets fell 8.73% to $281.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $281.4 million, marking a year-over-year decrease of 8.73%. This contributed to the annual value of $283.8 million for FY2024, which is 30.82% down from last year.
  • Per Adaptive Biotechnologies' latest filing, its Current Assets stood at $281.4 million for Q3 2025, which was up 7.48% from $261.9 million recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Current Assets ranged from a high of $765.0 million in Q1 2021 and a low of $256.5 million during Q1 2025.
  • Over the past 3 years, Adaptive Biotechnologies' median Current Assets value was $351.6 million (recorded in 2024), while the average stood at $358.3 million.
  • In the last 5 years, Adaptive Biotechnologies' Current Assets slumped by 46.77% in 2021 and then surged by 39.58% in 2022.
  • Quarterly analysis of 5 years shows Adaptive Biotechnologies' Current Assets stood at $402.7 million in 2021, then spiked by 39.58% to $562.1 million in 2022, then decreased by 27.03% to $410.2 million in 2023, then crashed by 30.82% to $283.8 million in 2024, then dropped by 8.73% to $281.4 million in 2025.
  • Its Current Assets stands at $281.4 million for Q3 2025, versus $261.9 million for Q2 2025 and $256.5 million for Q1 2025.